Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38, showing anticancer activity. Sacituzumab govitecan has a molecular weight of 160KDa.Can be dissolved and diluted with PBS.
[1] Cardillo TM, et al. Bioconjug Chem. 2015 May 20;26(5):919-31.
















